|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holschneider CH and Berek JS: Ovarian
cancer: Epidemiology, biology, and prognostic factors. Semin Surg
Oncol. 19:3–10. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Klint A, Tryggvadóttir L, Bray F, Gislum
M, Hakulinen T, Storm HH and Engholm G: Trends in the survival of
patients diagnosed with cancer in female genital organs in the
Nordic countries 1964–2003 followed up to the end of 2006. Acta
Oncol. 49:632–643. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Markman M, Bundy BN, Alberts DS, Fowler
JM, Clark-Pearson DL, Carson LF, Wadler S and Sickel J: Phase III
trial of standard-dose intravenous cisplatin plus paclitaxel versus
moderately high-dose carboplatin followed by intravenous paclitaxel
and intraperitoneal cisplatin in small-volume stage III ovarian
carcinoma: An intergroup study of the Gynecologic Oncology Group,
Southwestern Oncology Group, and Eastern Cooperative Oncology
Group. J Clin Oncol. 19:1001–1007. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Armstrong DK, Bundy B, Wenzel L, Huang HQ,
Baergen R, Lele S, Copeland LJ, Walker JL and Burger RA:
Gynecologic Oncology Group: Intraperitoneal cisplatin and
paclitaxel in ovarian cancer. N Engl J Med. 354:34–43. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Coleman MP, Forman D, Bryant H, Butler J,
Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, et al:
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and
the UK, 1995–2007 (the International Cancer Benchmarking
Partnership): An analysis of population-based cancer registry data.
Lancet. 377:127–138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baker J: Genomic Health, Inc.
Pharmacoqenomics. 8:397–399. 2007. View Article : Google Scholar
|
|
8
|
Zhan Y, Guo W, Zhang Y, Wang Q, Xu XJ and
Zhu L: A five-gene signature predicts prognosis in patients with
kidney renal clear cell carcinoma. Comput Math Methods Med.
2015:8427842015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
De Melo J and Tang D: Elevation of SIPL1
(SHARPIN) increases breast cancer risk. PLoS One. 10:e01275462015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Welsh JB, Zarrinkar PP, Sapinoso LM, Kern
SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA and Hampton GM:
Analysis of gene expression profiles in normal and neoplastic
ovarian tissue samples identifies candidate molecular markers of
epithelial ovarian cancer. Proc Natl Acad Sci USA. 98:1176–1181.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schwartz DR, Kardia SL, Shedden KA, Kuick
R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, et
al: Gene expression in ovarian cancer reflects both morphology and
biological behavior, distinguishing clear cell from other
poor-prognosis ovarian carcinomas. Cancer Res. 62:4722–4729.
2002.PubMed/NCBI
|
|
12
|
Schaner ME, Ross DT, Ciaravino G, Sorlie
T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S,
et al: Gene expression patterns in ovarian carcinomas. Mol Biol
Cell. 14:4376–4386. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bonome T, Lee JY, Park DC, Radonovich M,
Pise-Masison C, Brady J, Gardner GJ, Hao K, Wong WH, Barrett JC, et
al: Expression profiling of serous low malignant potential,
low-grade, and high-grade tumors of the ovary. Cancer Res.
65:10602–10612. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gilks CB, Vanderhyden BC, Zhu S, van de
Rijn M and Longacre TA: Distinction between serous tumors of low
malignant potential and serous carcinomas based on global mRNA
expression profiling. Gynecol Oncol. 96:684–694. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mok SC, Chao J, Skates S, Wong K, Yiu GK,
Muto MG, Berkowitz RS and Cramer DW: Prostasin, a potential serum
marker for ovarian cancer: Indentification through microarray
technology. J Natl Cancer Inst. 93:1458–1464. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Spentzos D, Levine DA, Kolia S, Otu H,
Boyd J, Libermann TA and Cannistra SA: Unique gene expression
profile based on pathologic response in epithelial ovarian cancer.
J Clin Oncol. 23:7911–7918. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li J, Chen Z, Tian L, Zhou C, He MY, Gao
Y, Wang S, Zhou F, Shi S, Feng X, et al: LncRNA profile study
reveals a three-lncRNA signature associated with the survival of
patients with oesophageal squamous cell carcinoma. Gut.
63:1700–1710. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nguyen HN, Averette HE, Hoskins W, Sevin
BU, Penalver M and Steren A: National survey of ovarian carcinoma.
VI. Critical assessment of current International Federation of
Gynecology and Obstetrics staging system. Cancer. 72:3007–3011.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baldwin LA, Huang B, Miller RW, Tucker T,
Goodrich ST, Podzielinski I, DeSimone CP, Ueland FR, van Nagell JR
and Seamon LG: Ten-year relative survival for epithelial ovarian
cancer. Obstet Gynecol. 120:612–618. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McCluggage WG: Morphological subtypes of
ovarian carcinoma: A review with emphasis on new developments and
pathogenesis. Pathology. 43:420–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Petrova P, Raibekas A, Pevsner J, Vigo N,
Anafi M, Moore MK, Peaire AE, Shridhar V, Smith DI, Kelly J, et al:
MANF: A new mesencephalic, astrocyte-derived neurotrophic factor
with selectivity for dopaminergic neurons. J Mol Neurosci.
20:173–188. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Apostolou A, Shen Y, Liang Y, Luo J and
Fang S: Armet, a UPR-upregulated protein, inhibits cell
proliferation and ER stress-induced cell death. Exp Cell Res.
314:2454–2467. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lindahl M, Danilova T, Palm E, Lindholm P,
Võikar V, Hakonen E, Ustinov J, Andressoo JO, Harvey BK, Otonkoski
T, et al: MANF is indispensable for the proliferation and survival
of pancreatic β cells. Cell Rep. 7:366–375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Palgi M, Greco D, Lindström R, Auvinen P
and Heino TI: Gene expression analysis of Drosophilaa Manf mutants
reveals perturbations in membrane traffic and major metabolic
changes. BMC Genomics. 13:1342012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Szegezdi E, Logue SE, Gorman AM and Samali
A: Mediators of endoplasmic reticulum stress-induced apoptosis.
EMBO Rep. 7:880–885. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang YM, Yang Y, Dai WW, Li XM, Ma JQ and
Tang LP: Genistein-induced apoptosis is mediated by endoplasmic
reticulum stress in cervical cancer cells. Eur Rev Med Pharmacol
Sci. 20:3292–3296. 2016.PubMed/NCBI
|
|
28
|
Yeh TC, Chiang PC, Li TK, Hsu JL, Lin CJ,
Wang SW, Peng CY and Guh JH: Genistein induces apoptosis in human
hepatocellular carcinomas via interaction of endoplasmic reticulum
stress and mitochondrial insult. Biochem Pharmacol. 73:782–792.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
El Jamal SM, Taylor EB, Elmageed Abd ZY,
Alamodi AA, Selimovic D, Alkhateeb A, Hannig M, Hassan SY,
Santourlidis S, Friedlander PL, et al: Interferon gamma-induced
apoptosis of head and neck squamous cell carcinoma is connected to
indoleamine-2,3-dioxygenase via mitochondrial and ER
stress-associated pathways. Cell Division. 11:112016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen L, Feng L, Wang X, Du J, Chen Y, Yang
W, Zhou C, Cheng L, Shen Y, Fang S, et al: Mesencephalic
astrocyte-derived neurotrophic factor is involved in inflammation
by negatively regulating the NF-κB pathway. Sci Rep. 5:81332015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rossman KL, Der CJ and Sondek J: GEF means
go: Turning on RHO GTPases with guanine nucleotide-exchange
factors. Nat Rev Mol Cell Biol. 6:167–180. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meller N, Irani-Tehrani M, Kiosses WB, Del
Pozo MA and Schwartz MA: Zizimin1, a novel Cdc42 activator, reveals
a new GEF domain for Rho proteins. Nat Cell Biol. 4:639–647. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gadea G and Blangy A: Dock-family exchange
factors in cell migration and disease. Eur J Cell Biol. 93:466–477.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cook DR, Rossman KL and Der CJ: Rho
guanine nucleotide exchange factors: Regulators of Rho GTPase
activity in development and disease. Oncogene. 33:4021–4035. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Côté JF and Vuori K: Identification of an
evolutionarily conserved superfamily of DOCK180-related proteins
with guanine nucleotide exchange activity. J Cell Sci.
115:4901–4913. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nishikimi A, Meller N, Uekawa N, Isobe K,
Schwartz MA and Maruyama M: Zizimin2: A novel, DOCK180-related
Cdc42 guanine nucleotide exchange factor expressed predominantly in
lymphocytes. FEBS Lett. 579:1039–1046. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin Q, Yang W, Baird D, Feng Q and Cerione
RA: Identification of a DOCK180-related guanine nucleotide exchange
factor that is capable of mediating a positive feedback activation
of Cdc42. J Biol Chem. 281:35253–35262. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sakabe I, Asai A, Iijima J and Maruyama M:
Age-related guanine nucleotide exchange factor, mouse Zizimin2,
induces filopodia in bone marrow-derived dendritic cells. Immun
Ageing. 9:22012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jing YY, Han ZP, Sun K, Zhang SS, Hou J,
Liu Y, Li R, Gao L, Zhao X, Zhao QD, et al: Toll-like receptor 4
signaling promotes epithelial-mesenchymal transition in human
hepatocellular carcinoma induced by lipopolysaccharide. BMC Med.
10:982012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liao SJ, Zhou YH, Yuan Y, Li D, Wu FH,
Wang Q, Zhu JH, Yan B, Wei JJ, Zhang GM and Feng ZH: Triggering of
Toll-like receptor 4 on metastatic breast cancer cells promotes
αvβ3-mediated adhesion and invasive migration. Breast Cancer Res
Treat. 133:853–863. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rakhesh M, Cate M, Vijay R, Shrikant A and
Shanjana A: A TLR4-interacting peptide inhibits
lipopolysaccharide-stimulated inflammatory responses, migration and
invasion of colon cancer SW480 cells. Oncoimmunology. 1:1495–1506.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Almstrup K, Leffers H, Lothe RA,
Skakkebaek NE, Sonne SB, Nielsen JE, Rajpert-De Meyts E and
Skotheim RI: Improved gene expression signature of testicular
carcinoma in situ. Int J Androl. 30:292–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pontén F, Jirström K and Uhlen M: The
human protein atlas-a tool for pathology. J Pathol. 216:387–393.
2008. View Article : Google Scholar : PubMed/NCBI
|
